Lister team at heart of major international urology research trial

The Lister urology team is leading a multi-centre international research trial involving hospitals from the UK, Belgium and the United States.  

The trial, called the Robotic Guided Cytokine Study, is being lead by Mr Nikhil Vasdev, consultant urological surgeon and senior lecturer in collaboration with the University of Hertfordshire. To date 20 patients have been recruited successfully at the Lister to what is the world’s first study looking at the role of cytokines in robotic urological surgery.  

Above from left to right: Mr Simon Alesbury (Lawmed), Dr Karel Decaestecker (consultant urologist at the University of Ghent), Mr Gary Tegan (senior director of clinical affairs at Conmed), Mr Nikhil Vasdev (consultant urologist at the Trust and chef investigator for the trial), Dr Gowrie Mohan (consultant anesthetist at the Trust) and Mr Nimish Shah (consultant urologist at Addenbrookes hospital, Cambridge)

Cytokines are cell signalling molecules that aid cell-to-cell communication in immune responses and stimulate the movement of cells towards sites of inflammation, infection and trauma. The study is looking at optimising intra-abdominal pressures during robotic surgery to improve post-operative outcomes in patients undergoing robotic urological surgery. 

The trial started originally at the Lister in 2017 and is rolling out to Cambridge, Belgium and USA in February 2018. Pilot data from the study has been accepted for presentation at the European Urology Association meeting that takes place in Copenhagen in March 2018.

Commenting on the trial, chief investigator Nikhil Vadev said:  “I am very proud to lead the world’s first study looking at robotic urological surgery and cytokines .  We now look forward  to collaborating with international, high-volume robotic urology centres of excellence.”